The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Open accessAbstract
BACKGROUND: Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested. METHODS: In this study involving 4038 patients with diabetes, chronic kidney disease, and anemia, we randomly assigned 2012 patients to darbepoetin alfa to achieve a hemoglobin level of approximately 13 g per deciliter and 2026 patients to placebo, with rescue darbepoetin alfa when the hemoglobin level was less than 9.0 g per deciliter. The primary end points were the composite outcomes of death or a cardiovascular event (nonfatal myocardial infarction, congestive heart failure, stroke, or hospitalization for myocardial ischemia) and of death or end-stage renal disease. RESULTS: Death or a cardiovascular event occurred in 632 patients assigned to darbepoetin alfa and 602 patients assigned to placebo (hazard ratio for darbepoetin alfa vs. placebo, 1.05; 95% confidence interval [CI], 0.94 to 1.17; P=0.41). Death or end-stage renal disease occurred in 652 patients assigned to darbepoetin alfa and 618 patients assigned to placebo (hazard ratio, 1.06; 95% CI, 0.95 to 1.19; P=0.29). Fatal or nonfatal stroke occurred in 101 patients assigned to darbepoetin alfa and 53 patients assigned to placebo (hazard ratio, 1.92; 95% CI, 1.38 to 2.68; P<0.001). Red-cell transfusions were administered to 297 patients assigned to darbepoetin alfa and 496 patients assigned to placebo (P<0.001). There was only a modest improvement in patient-reported fatigue in the darbepoetin alfa group as compared with the placebo group. CONCLUSIONS: The use of darbepoetin alfa in patients with diabetes, chronic kidney disease, and moderate anemia who were not undergoing dialysis did not reduce the risk of either of the two primary composite outcomes (either death or a cardiovascular event or death or a renal event) and was associated with an increased risk of stroke. For many persons involved in clinical decision making, this risk will outweigh the potential benefits. (ClinicalTrials.gov number, NCT00093015.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In pre-dialysis CKD patients with or without diabetes higher Hgb targets, particularly in patients with poor initial Hgb responses, were also associated with increased cardiovascular risk.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationLewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Self-citationStamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Self-citationCorrection of anemia with epoetin alfa in chronic kidney disease
Singh, A. K., Szczech, L., Tang, K. L., Barnhart, H., Sapp, S., Wolfson, M., & Reddan, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065485 · Cited by 2,762
Self-citationNormalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Drüeke, T. B., Locatelli, F., Clyne, N., Eckardt, K., Macdougall, I. C., Tsakiris, D., Burger, H.-U., & Scherhag, A. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062276 · Cited by 2,094
Self-citationEschbach, J. W., Abdulhadi, M. H., Browne, J. K., Delano, B. G., Downing, M. R., Egrie, J. C., Evans, R. W., Friedman, E. A., Graber, S. E., Haley, N. R., et al. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-12-992 · Cited by 795
Blood Pressure Lowering Treatment Trialists’ Collaboration (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1410 · Cited by 789
Booth, G. L., Kapral, M. K., Fung, K., & Tu, J. V. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68967-8 · Cited by 782
Flagged first, then by citations
Research works printed but not linked: 2
- Pfeffer MA, 2005, Rev Cardiovasc Med, 3, S35
- Strippoli GF, 2006, Cochrane Database Syst Rev, 4, CD003967
Cited by
Sorted by citations
Items 301–400 of 1,000
Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease
Winkelmayer, W. C. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.360 · Cited by 71
Cardiovascular disease in chronic kidney disease
Shah, A. P., & Mehrotra, R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3362-2.00031-2 · Cited by 68
Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients
Eckardt, K., Kim, J. D., Kronenberg, F., Aljama, P., Anker, S. D., Canaud, B., Molemans, B., Stenvinkel, P., Schernthaner, G., Ireland, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009101017 · Cited by 68
Self-citationA Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Garrick, R. (2010) · Yearbook of Medicine · doi:10.1016/s0084-3873(10)79646-2 · Cited by 68
Seliger, S. L., Zhang, A. D., Weir, M. R., Walker, L. D., Hsu, V. D., Parsa, A., Diamantidis, C. J., & Fink, J. C. (2011) · Kidney International · doi:10.1038/ki.2011.49 · Cited by 67
Goodkin, D. A., Fuller, D. S., Robinson, B. M., Combe, C., Fluck, R., Mendelssohn, D. C., Akizawa, T., Pisoni, R. L., & Port, F. K. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020173 · Cited by 67
Tsubakihara, Y., Gejyo, F., Nishi, S., Iino, Y., Watanabe, Y., Suzuki, M., Saitō, A., Akiba, T., Hirakata, H., & Akizawa, T. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2012.01082.x · Cited by 66
Yabu, J. M., & Winkelmayer, W. C. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01190211 · Cited by 66
Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease
Patel, D. M., Bose, M., & Cooper, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062218 · Cited by 65
Self-citationThe Initial Impact of Medicare's New Prospective Payment System for Kidney Dialysis
Hirth, R. A., Turenne, M. N., Wheeler, J. R. C., Nahra, T. A., Sleeman, K. K., Zhang, W., & Messana, J. M. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.044 · Cited by 65
Role of hypoxia in progressive chronic kidney disease and implications for therapy
Shoji, K., Tanaka, T., & Nangaku, M. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000441049.98664.6c · Cited by 66
Vecchio, L. D., & Locatelli, F. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1182494 · Cited by 65
Stoumpos, S., Crowe, K., Sarafidis, P. A., Barratt, J., Bolignano, D., Vecchio, L. D., Małyszko, J., Więcek, A., Ortíz, A., & Cozzolino, M. G. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae075 · Cited by 70
Anemia of chronic kidney disease: Treat it, but not too aggressively
Nakhoul, G., & Simon, J. F. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.15065 · Cited by 64
Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies
Haase, V. H. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.004 · Cited by 65
Ortíz, A., Ferro, C. J., Balafa, O. C., Burnier, M., Ekart, R., Halimi, J., Kreutz, R. H., Mark, P. B., Persu, A., Rossignol, P., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab167 · Cited by 64
Singh, A. K. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833cf1d6 · Cited by 63
Self-citationMima, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174583 · Cited by 63
Highlights on U.S. FDA-approved halogen-containing drugs in 2024
Ali, S., Tian, X., Meccia, S. A., & Zhou, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117380 · Cited by 63
Erythropoietin in Brain Development and Beyond
Alnaeeli, M., Wang, L., Piknova, B., Rogers, H. M., Li, X., & Noguchi, C. T. (2012) · Anatomy Research International · doi:10.1155/2012/953264 · Cited by 64
Effects of interventions on depression in heart failure: A systematic review
Woltz, P. C., Chapa, D. W., Friedmann, E., Son, H., Akintade, B. F., & Thomas, S. A. (2012) · Heart & Lung · doi:10.1016/j.hrtlng.2012.06.002 · Cited by 63
Nitric Oxide and Hypoxia Signaling
Man, H. S. J., Tsui, A. K. Y., & Marsden, P. A. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00007-6 · Cited by 65
Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes
Gregg, L. P., Jain, N., Carmody, T. J., Minhajuddin, A., Rush, A. J., Trivedi, M. H., & Hedayati, S. S. (2019) · American Journal of Nephrology · doi:10.1159/000500668 · Cited by 63
State of the art papers Lipids, blood pressure, kidney – what was new in 2011?
Barylski, M., Małyszko, J., Rysz, J., Myśliwiec, M., & Banach, M. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.26620 · Cited by 62
Jeong, S., Cho, Y. I., Duey, M., & Rosenson, R. S. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6239-7 · Cited by 62
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Hasegawa, S., Tanaka, T., & Nangaku, M. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000431 · Cited by 63
Susantitaphong, P., Alqahtani, F., & Jaber, B. L. (2014) · American Journal of Nephrology · doi:10.1159/000358336 · Cited by 61
Kshirsagar, A. V., Freburger, J. K., Ellis, A. R., Wang, L., Winkelmayer, W. C., & Brookhart, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078930 · Cited by 61
Individualized Anemia Management Reduces Hemoglobin Variability in Hemodialysis Patients
Gawęda, A. E., Aronoff, G. R., Jacobs, A. A., Rai, S. N., & Brier, M. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010089 · Cited by 61
Management of anemia of inflammation in the elderly
Macciò, A., & Madeddu, C. (2012) · Anemia · doi:10.1155/2012/563251 · Cited by 60
Anaemia in CKD—treatment standard
Macdougall, I. C. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad250 · Cited by 64
Risk of Stroke in Patients with ESRD
Masson, P., Kelly, P. J., Craig, J. C., Lindley, R. I., & Webster, A. C. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12001214 · Cited by 60
Uraemic Cardiomyopathy: A Review of Current Literature
Garikapati, K., Goh, D. S. L., Khanna, S., & Echampati, K. (2021) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546821998347 · Cited by 62
Changing Patterns of Anemia Management in US Hemodialysis Patients
Freburger, J. K., Ng, L. J., Bradbury, B. D., Kshirsagar, A. V., & Brookhart, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.03.011 · Cited by 59
Beverborg, N. G., Verweij, N., Klip, I. T., van der Wal, H. H., Voors, A. A., van Veldhuisen, D. J., Gansevoort, R. T., Bakker, S. J. L., van der Harst, P., & van der Meer, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125215 · Cited by 59
Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease
Li, J., Luo, J., Jiang, Y., Ma, Y., Ji, Y., Zhu, G., Zhou, C., Chu, H.-W., & Zhang, H. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000502525 · Cited by 60
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.35 · Cited by 60
Nair, D., & Wilson, F. P. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.025 · Cited by 58
Tsui, A. K. Y., Marsden, P. A., Mazer, C. D., Sled, J. G., Lee, K. M., Henkelman, R. M., Cahill, L. S., Zhou, Y., Chan, N., Liu, E., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00411.2013 · Cited by 59
Diabetic nephropathy: newer therapeutic perspectives
Keri, K., Samji, N. S., & Blumenthal, S. S. (2018) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2018.1500423 · Cited by 60
Posttransplantation Anemia in Kidney Transplant Recipients
Gafter‐Gvili, A., & Gafter, U. (2019) · Acta Haematologica · doi:10.1159/000496140 · Cited by 58
Bello, N. A., Pfeffer, M. A., Skali, H., McGill, J. B., Rossert, J., Olson, K. A., Weinrauch, L. A., Cooper, M. E., de Zeeuw, D., Rossing, P. R., et al. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2013-000011 · Cited by 57
Self-citationvan Nooten, F. E., Green, J., Brown, R. E., Finkelstein, F. O., & Wish, J. B. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.484307 · Cited by 57
Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?
Singh, A. K. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009111127 · Cited by 57
Self-citationGlomerular filtration rate decline as a surrogate end point in kidney disease progression trials
Badve, S. V., Palmer, S. C., Hawley, C. M., Pascoe, E. M., Strippoli, G. F., & Johnson, D. W. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv269 · Cited by 56
New Anemia Therapies: Translating Novel Strategies From Bench to Bedside
Macdougall, I. C. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.013 · Cited by 57
Chung, E. Y. M., Palmer, S. C., Saglimbene, V. M., Craig, J. C., Tonelli, M. A., & Strippoli, G. F. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010590.pub3 · Cited by 59
Robinson, B. M., Fuller, D. S., Zinsser, D., Albert, J. M., Gillespie, B. W., Tentori, F., Turenne, M. N., Port, F. K., & Pisoni, R. L. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.03.001 · Cited by 56
Hung, S., Kuo, K., Peng, C., Wu, C., Wang, Y., & Tarng, D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001480 · Cited by 56
Sun, C. C., Vaja, V., Chen, S., Theurl, I., Stepanek, A. M., Brown, D. E., Cappellini, M. D., Weiss, G., Hong, C. C., Lin, H. Y.-F., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs584 · Cited by 56
Association between the malnutrition-inflammation score and post-transplant anaemia
Molnar, M. Z., Czira, M. E., Rudas, A., Újszászi, Á., Haromszeki, B., Kosa, J. P., Lakatos, P. L., Bekő, G., Sárváry, E., Varga, M. Z., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq690 · Cited by 56
Reinhart, W. H. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168032 · Cited by 57
Heuberger, J. A. A. C., Rotmans, J. I., Gal, P., Stuurman, F. E., Westende, J. V. '., Post, T. E., Daniels, J. M. A., Moerland, M., van Veldhoven, P. L. J., de Kam, M. L., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30105-9 · Cited by 56
Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia
Ogoshi, Y., Matsui, T., Mitani, I., Yokota, M., Terashita, M., Motoda, D., Ueyama, K., Hotta, T., Ito, T., Hase, Y., et al. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00404 · Cited by 56
Zelnick, L. R., Batacchi, Z. O., Ahmad, I., Dighe, A., Little, R. R., Trence, D. L., Hirsch, I. B., & de Boer, I. H. (2020) · Diabetes Care · doi:10.2337/dc20-0915 · Cited by 55
Bross, M. H., Soch, K., & Smith-Knuppel, T. (2010) · PubMed · Cited by 55
Xie, H., Wang, Q., Zhang, X., Wang, T., Hu, W., Manicum, T., Chen, H., & Sun, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.131 · Cited by 55
Adverse Events Associated with Testosterone Administration
Weikert, C., Pischon, T., & Weikert, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1009326 · Cited by 55
Anaemia, Haemoglobin Level and Cause-Specific Mortality in People with and without Diabetes
Kengne, A. P., Czernichow, S., Hamer, M., Batty, G. D., & Stamatakis, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041875 · Cited by 54
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform
Chertow, G. M., Liu, J., Monda, K. L., Gilbertson, D. T., Brookhart, M. A., Beaubrun, A. C., Winkelmayer, W. C., Pollock, A. S., Herzog, C. A., Ashfaq, A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015111232 · Cited by 54
Schreiber, K. I., Magyari, M., Sellebjerg, F. T., Iversen, P., Garde, E., Madsen, C. G., Börnsen, L. S., Christensen, J. R., Ratzer, R. L., Siebner, H. R., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516661048 · Cited by 54
Fandrey, J., Schödel, J., Eckardt, K., Katschinski, D. M., & Wenger, R. H. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02334-8 · Cited by 54
Self-citationAkizawa, T., Nangaku, M., Yamaguchi, T., Koretomo, R., Maeda, K., Miyazawa, Y., & Hirakata, H. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.04.037 · Cited by 54
Akizawa, T., Gejyo, F., Nishi, S., Iino, Y., Watanabe, Y., Suzuki, M., Saitō, A., Akiba, T., Hirakata, H., Fukuhara, S., et al. (2011) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2011.00931.x · Cited by 54
Locatelli, F., Minutolo, R., Nicola, L. D., & Vecchio, L. D. (2022) · Drugs · doi:10.1007/s40265-022-01783-3 · Cited by 53
Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
Tanaka, T., & Nangaku, M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.035 · Cited by 53
Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment
Granata, A. R. M., Clementi, A., Virzì, G. M., Brocca, A., de Cal, M., Scarfia, R. V., Zanoli, L., Ronco, C., Corrao, S., & Malatino, L. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.02.019 · Cited by 54
Covic, A. C., Jackson, J., Hadfield, A., Pike, J., & Siriopol, D. C. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0566-z · Cited by 55
Noonan, M. L., Clinkenbeard, E. L., Ni, P., Swallow, E. A., Tippen, S. P., Agoro, R., Allen, M. R., & White, K. E. (2020) · Physiological Reports · doi:10.14814/phy2.14434 · Cited by 53
Anemia and Erythrocytosis in patients after kidney transplantation
Małyszko, J., Oberbauer, R. W., & Watschinger, B. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01513.x · Cited by 52
Sugahara, M., Tanaka, T., & Nangaku, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108272 · Cited by 52
Novel therapies in acute and chronic heart failure
Aronson, D., & Krum, H. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.002 · Cited by 51
Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
Herrington, W. G., Haynes, R., Staplin, N., Emberson, J., Baigent, C., & Landray, M. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12281 · Cited by 51
Epo and Non-hematopoietic Cells: What Do We Know?
Ogunshola, O. O., & Bogdanova, A. Y. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-308-4_2 · Cited by 51
Erythropoiesis stimulating agents and reno-protection: a meta-analysis
Elliott, S., Tomita, D. K., & Endre, Z. H. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0438-4 · Cited by 51
New options for the anemia of chronic kidney disease
Coyne, D. W., Goldsmith, D. J. A., & Macdougall, I. C. (2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.09.002 · Cited by 52
Yamamoto, H., Nobori, K., Matsuda, Y., Hayashi, Y., Hayasaki, T., & Akizawa, T. (2021) · American Journal of Nephrology · doi:10.1159/000518072 · Cited by 51
Sánchez, J. J. G., Thompson, J. C., Scott, D. A., Evans, R., Rao, N., Sörstadius, E., James, G., NOLAN, S. T., Wittbrodt, E. T., Sultan, A. A., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-02006-z · Cited by 53
Abbasi, M. A., Chertow, G. M., & Hall, Y. N. (2005) · PubMed Central · Cited by 51
Pathophysiology of Anemia in Heart Failure
Anand, I. S. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.03.002 · Cited by 50
Anemia is Associated with Poor Outcomes in Patients with Less Severe Ischemic Stroke
Sico, J. J., Concato, J., Wells, C. K., Lo, A., Nadeau, S. E., Williams, L. S., Peixoto, A. J., Gorman, M., Boice, J. L., & Bravata, D. M. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.09.003 · Cited by 50
Iron and vascular calcification. Is there a link?
Neven, E., Schutter, T. M. D., Behets, G. J. S., Gupta, A., & D’Haese, P. C. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq858 · Cited by 51
Evidence-Based Cardiology in Hemodialysis Patients
Allon, M. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060632 · Cited by 52
Padmanabhan, H., Siau, K., Nevill, A. M., Morgan, I. S., Cotton, J. M., Ng, A., Brookes, M., & Luckraz, H. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy226 · Cited by 51
Erythropoietin in cancer patients: pros and cons
Dicato, M. A., & Plawny, L. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833aa9de · Cited by 49
Garimella, P. S., Katz, R., Patel, K. V., Kritchevsky, S. B., Parikh, C. R., Ix, J. H., Fried, L. F., Newman, A. B., Shlipak, M. G., Harris, T. B., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002124 · Cited by 49
Tsujita, M., Kosugi, T., Goto, N., Futamura, K., Nishihira, M., Okada, M., Hiramitsu, T., Narumi, S., Uchida, K., Takeda, A., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy365 · Cited by 49
Silverberg, D. S. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9194-2 · Cited by 48
Macdougall, I. C., White, C., Anker, S. D., Bhandari, S., Farrington, K., Kalra, P. A., McMurray, J. J. V., Murray, H. M., Steenkamp, R. D., Tomson, C., et al. (2018) · American Journal of Nephrology · doi:10.1159/000493551 · Cited by 49
Self-citationHirani, V., Naganathan, V., Blyth, F., Couteur, D. G. L., Kelly, P. J., Handelsman, D. J., Waite, L. M., & Cumming, R. G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.02.014 · Cited by 48
Hasegawa, T., Bragg‐Gresham, J. L., Pisoni, R. L., Robinson, B. M., Fukuhara, S., Akiba, T., Saitō, A., Kurokawa, K., & Akizawa, T. (2010) · Kidney International · doi:10.1038/ki.2010.382 · Cited by 48
Inrig, J. K., Barnhart, H. X., Reddan, D. N., Patel, U. D., Sapp, S. K., Califf, R. M., Singh, A. K., & Szczech, L. A. M. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.03.009 · Cited by 48
Self-citationWu, I., Hsu, K., Sun, C., Tsai, C.-J., Wu, M., & Lee, C. C. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu061 · Cited by 48
Dialysis-Induced Myocardial Stunning: The Other Side of the Cardiorenal Syndrome
Breidthardt, T., & McIntyre, C. W. (2011) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0585 · Cited by 48
Cernaro, V., Coppolino, G., Visconti, L., Rivoli, L., Lacquaniti, A., Santoro, D., Buemi, A., Loddo, S., & Buemi, M. (2018) · Medicinal Research Reviews · doi:10.1002/med.21527 · Cited by 48
A 24‐Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients
Tsubakihara, Y., Akizawa, T., Nangaku, M., Onoue, T., Yonekawa, T., Matsushita, H., Endo, Y., & Cobitz, A. R. (2019) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12962 · Cited by 48
Zoppini, G., Targher, G., Chonchol, M., Negri, C., Stoico, V., Pichiri, I., Lippi, G., Muggeo, M., & Bonora, E. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.008 · Cited by 48
Minutolo, R., Liberti, M. E., Simeon, V., Sasso, F. C., Borrelli, S., Nicola, L. D., & Garofalo, C. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad143 · Cited by 47
Sarafidis, P. A., Iatridi, F., Ferro, C. J., Alexandrou, M. E., Fernández‐Fernández, B., Kanbay, M., Mallamaci, F., Nistor, I., Rossignol, P., Wanner, C., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad139 · Cited by 47
Chang, W., Asakawa, S., Toyoki, D., Nemoto, Y., Morimoto, C., Tamura, Y., Ota, T., Shibata, S., Fujigaki, Y., Shen, Z. Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132927 · Cited by 47
Metadata
- Authors
- Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., Lewis, E. F., McGill, J. B., McMurray, J. J. V., Parfrey, P., Parving, H.-H., Remuzzi, G., Singh, A. K., Solomon, S. D., & Toto, R.
- Affiliations
- Brigham and Women's Hospital (US)
- Hospital de Base (BR)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Wisconsin–Madison (US)
- Northwestern University (US)
- Tufts University (US)
- Harvard University (US)
- Washington University in St. Louis (US)
- University of Glasgow (GB)
- University of Copenhagen (DK)
- The University of Texas Southwestern Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-11-19
- Volume
- 361
- Issue
- 21
- Pages
- 2019-2032
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1998943227
- Cited by
- 2,096
- References
- 32
- Citations by year
- 2026: 62 · 2025: 66 · 2024: 65 · 2023: 94 · 2022: 92 · 2021: 128 · 2020: 121 · 2019: 111 · 2018: 90 · 2017: 108 · 2016: 125 · 2015: 122 · 2014: 163 · 2013: 174 · 2012: 175
- FWCI
- 125.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Robert Wood Johnson Foundation
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Biogen
- Louisiana Board of Regents
- Boston Scientific Corporation
- McGill University
- Celladon Corporation
- Covis Pharma
- Cytokinetics
- Servier
- Genentech
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- darbepoetin alfa, type 2 diabetes, chronic kidney disease, anemia, erythropoiesis-stimulating agents, cardiovascular events, end-stage renal disease, stroke, red blood cell transfusion, fatigue, hemoglobin target, cardiovascular risk reduction, non-dialysis patients
- MeSH terms
- Darbepoetin alfa, Aged, Anemia, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Double-Blind Method, Erythropoietin, Female, Hematinics, Hemoglobins, Humans, Kidney Failure, Chronic, Male, Middle Aged, Neoplasms, Stroke, Renal Insufficiency, Chronic, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
